Nectar Lifesciences share price
NECLIFE on NSE · data as of 16 Oct 2026
Nectar Lifesciences closed at ₹10.54 on 16 Oct 2026 (+4.98% on the day). It is 52.9% below its 52-week high of ₹22.40 (23 Dec 2025) and 13.3% above its 52-week low of ₹9.30 (30 Mar 2026). The stock has underperformed the Nifty 50 over the past year (-25.2% vs -8.5%). It is trading below both its 50-day and 200-day averages (a downtrend), with RSI 47 (neutral zone).
Technical snapshot
- 20-day averagebelow, 0.3%
- 50-day averagebelow, 4.9%
- 200-day averagebelow, 14.0%
- RSI (14)47 neutral zone
- MACDbelow signal line
- Typical daily move1.6% last 20 days
- Beta vs Nifty 500.99 moves about with the market
- Traded value today₹0.2 cr 1.3x the 20-day average volume
- Delivery82% 20-day avg 75%
Key levels
- Nearest resistance₹10.97 4.1% above
- Nearest support₹10.17 3.5% below
- Position in 52-week range9% 0 = low, 100 = high
Weekly pivot levels
Chart pattern
No clear double or triple top or bottom, or head-and-shoulders shape, in the last six months.
Support and resistance are recent swing lows and highs; pivots come from last week's high, low and close. Patterns and candles describe past prices only. They are not predictions or buy/sell signals. See the glossary for terms.
Where the price sits
Last 12 months
Weekly closing prices, adjusted for splits and bonus issues.
Returns vs Nifty 50
| Period | NECLIFE | Nifty 50 | Gap |
|---|---|---|---|
| 1 week | +4.0% | +2.8% | +1.2 pts |
| 1 month | −3.3% | −0.3% | −3.0 pts |
| 3 months | −2.9% | −4.9% | +2.0 pts |
| 6 months | −15.1% | −4.3% | −10.8 pts |
| 1 year | −25.2% | −8.5% | −16.7 pts |
Gap = the stock's return minus the Nifty 50's, in percentage points. New to these terms? See 52-week high, moving average and RSI.
Quick answers
What is the 52-week high of Nectar Lifesciences?
The 52-week high of Nectar Lifesciences (NECLIFE) is ₹22.40, reached on 23 Dec 2025. The 52-week low is ₹9.30, on 30 Mar 2026 (NSE, as of 16 Oct 2026).
How has Nectar Lifesciences performed in the last year?
Over the last year the share price has moved -25.2%, compared with -8.5% for the Nifty 50 (as of 16 Oct 2026). Past returns do not predict future returns.
Does Nectar Lifesciences show a chart pattern?
As of 16 Oct 2026, there is no clear double or triple top or bottom, or head-and-shoulders shape, in the last six months.
Is Nectar Lifesciences in an uptrend?
As of 16 Oct 2026, Nectar Lifesciences is trading below both its 50-day and 200-day averages (a downtrend), with RSI 47 (neutral zone). Trend describes the past, not what happens next.
Price facts only, refreshed every trading day. Not a recommendation to buy or sell. Education only. Not investment advice. All stocks · Today's stock lists